OMEGA HEALTHCARE INVESTORS INC annual report, FY2017

Omega Healthcare Investors, Inc. — 2017 Form 10-K Summary

Business context and reporting period

Annual report for the fiscal year ended December 31, 2017, filed February 23, 2018. Omega is a healthcare REIT operating through OHI Healthcare Properties Limited Partnership. Its portfolio primarily consists of long-term, triple-net leases and fixed-rate mortgage investments in skilled nursing and assisted living facilities across 41 U.S. states and the United Kingdom.

  • Portfolio: 983 facilities, approximately 97,637 beds and 74 third-party operators.
  • Investment portfolio: approximately $8.8 billion in healthcare facilities, plus $276.3 million of other investments and a $36.5 million unconsolidated joint venture investment.
  • Approximately 99% of real estate investments relate to long-term healthcare facilities.
  • Omega owned approximately 96% of Omega OP at year-end; outside investors owned approximately 4%.

Financial results and key metrics

Metric20172016Change
Total operating revenues$908.4 million$900.8 million+$7.6 million
Net income$104.9 million$383.4 million-$278.5 million
Net income available to common stockholders$100.4 million$366.4 million-$266.0 million
Diluted EPS$0.51$1.90-$1.39
NAREIT FFO$444.3 million$660.1 million-$215.8 million
Operating cash flow$577.9 million$624.8 million-$46.9 million
Cash, cash equivalents and restricted cash$96.8 million$107.3 million-$10.5 million
Total debt$4.6 billion$4.4 billionIncreased
Total equity$3.9 billion$4.2 billionDecreased

Revenue was broadly stable because higher rental income and other investment income offset lower direct financing lease income and mortgage interest income. The decline in profitability primarily reflected $198.2 million of direct financing lease impairments, $99.1 million of real estate impairments, higher interest expense and refinancing costs.

  • Rental income increased to $775.2 million from $743.9 million.
  • Direct financing lease income declined to $32.3 million from $62.3 million, principally because Orianna was placed on a cash basis.
  • Mortgage interest income declined to $66.2 million from $69.8 million.
  • Operating expenses increased to $647.1 million from $391.1 million.
  • Net income margin was approximately 11.5%, compared with approximately 42.6% in 2016; the comparison was heavily affected by impairment and restructuring-related items.
  • Dividends declared increased to $2.54 per share from $2.36; $502.6 million of common dividends were paid in 2017.

Material changes versus the prior comparable period

  • Omega completed approximately $559 million of new investments, including 18 U.K. care homes, 15 Indiana SNFs, additional U.S. SNFs and ALFs, a mortgage loan and capital expenditure programs.
  • The Company sold 52 facilities for approximately $257.8 million of net proceeds and recorded approximately $53.9 million of net gains.
  • Year-end assets held for sale increased to $86.7 million covering 22 facilities, from $52.9 million covering 20 properties.
  • In April 2017, Omega issued $550 million of 4.75% senior notes due 2028 and $150 million of additional 4.50% notes due 2025. Proceeds were used to redeem $400 million of 5.875% notes, repay a $200 million term loan and reduce revolver borrowings.
  • In May 2017, Omega established new $1.8 billion senior unsecured revolving and term loan facilities, with an accordion feature allowing total commitments to increase to $2.5 billion subject to conditions.
  • Debt represented approximately 54% of total capitalization at December 31, 2017. The Company reported compliance with its debt covenants.
  • Operating cash flow declined as contractual receivables increased, particularly from troubled operators.

Outlook, management commentary, risks and unusual items

Management stated that occupancy and operator coverage levels remained stable during 2017, while labor costs, liability costs, reimbursement changes and regulatory enforcement created increasing pressure on skilled nursing operators. Management believed operators could generally absorb moderate Medicare and Medicaid reimbursement reductions, except for certain operators already behind on rent.

  • Orianna: Orianna had not paid rent since July 2017. Omega recognized no related direct financing lease income after June 30, 2017 and recorded a $172.2 million allowance on 38 facilities. The remaining net direct financing lease investment was $337.7 million, and future resolution could materially affect results.
  • Signature: Signature was more than 90 days past due. Omega cited a letter of credit exceeding $9.0 million and principal guarantees, and was pursuing an out-of-court restructuring involving rent deferrals and a working capital loan.
  • Daybreak: Daybreak was placed on a cash basis in the third quarter. A forbearance agreement allowed temporary rent deferrals; monthly rent reportedly returned to the full contractual amount in January 2018.
  • Impairments and dispositions: 2017 included $99.1 million of real estate impairments, $198.2 million of direct financing lease impairments and a $46.4 million fourth-quarter gain on asset sales. One facility impairment of $12.6 million related to a fire.
  • Commitments: Remaining commitments for construction and capital improvements totaled approximately $298.7 million at year-end.
  • Litigation: Two purported securities class actions were filed in November 2017 concerning disclosures about operator performance, rent collections, impairments and receivables. The Company could not estimate potential costs or predict the outcome.
  • Tax and REIT status: Omega intended to maintain its REIT qualification and generally must distribute at least 90% of REIT taxable income. The Tax Cuts and Jobs Act was enacted in December 2017; management preliminarily assessed its financial statement impact as immaterial.
  • Formal guidance: The filing does not provide a specific earnings, FFO or revenue guidance range. Management stated that available liquidity was expected to fund operations, debt service, dividends and investments over the next twelve months.

Most important facts for investors to verify

  • Resolution of the Orianna portfolio, including collections, lease transitions, asset sales and any additional impairment exposure.
  • Progress and final terms of the Signature restructuring and continued payment performance by Daybreak and other delinquent operators.
  • Operator coverage ratios, occupancy, labor costs and exposure to Medicare and Medicaid reimbursement reductions.
  • Debt maturities, variable-rate exposure, refinancing needs and compliance with financial covenants.
  • Whether the $298.7 million of remaining capital commitments can be funded while maintaining dividends and leverage targets.
  • Disposition proceeds and carrying values for the 22 facilities held for sale.
  • Potential financial or disclosure consequences of the securities class actions and other operator-related investigations or litigation.
  • Sustainability of the $2.54 per-share dividend relative to recurring cash flow and FFO, recognizing that 2017 distributions included $0.932 per share classified as return of capital for tax purposes.